iCreatAI News
Skip to content
TechCrunch · AI· Ram Iyer·· 11 hr agoAI score71

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

AI summary

Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and all existing backers also participating. The company said its AI drug-design engine, built on DeepMind's AlphaFold work, has yielded "positive preclinical results" in oncology and immunology, and it has struck deals with Eli Lilly, Novartis, and Johnson & Johnson. The funding, following a $2.1 billion Series B in May, will go toward developing its drug-design engine and expanding into more types of medicine; Isomorphic did not disclose its new valuation.

Source: TechCrunch · AI · techcrunch.com